Yongsheng Liu

9PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersAerospace structuresCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 13, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.

Vladimir Tolmachev, Anzhelika Vorobyeva, Alia Hani Binti Rosly

|May 13, 2023
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab.

Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva

|Nov 26, 2022
Biologic Evaluation of a Heterodimeric HER2-Albumin Targeted Affibody Molecule Produced by Chemo-Enzymatic Peptide Synthesis.

Yongsheng Liu, Rezan Güler, Yunqi Liao

|Sep 23, 2022
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3.

Maryam Oroujeni, Ekaterina A Bezverkhniaia, Tianqi Xu

|Aug 26, 2022
Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart.

Javad Garousi, Tianqi Xu, Yongsheng Liu

|Jul 27, 2022
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT.

Yongsheng Liu, Shengze Yu, Tianqi Xu

Pageof 2

Frequent Collaborators

9 joint publications

Anna Orlova

9 joint publications

Vladimir Tolmachev

8 joint publications

Anzhelika Vorobyeva

7 joint publications

Tianqi Xu